Healthcare Upcoming Trends and Topics Companion Diagnostics Market, By End User | Page 2

• The global Companion Diagnostics market is projected to reach USD 6.51
Billion by 2022 from USD 2.61 Billion in 2017, at a CAGR of 20.1%. The growth
of market is majorly driven by the factors such as improvements in regulatory
guidelines, growing need for targeted therapies, rising cancer incidence across
the globe, and increasing collaborations and partnerships for companion
diagnostics test development.
• On the basis of technology, the companion diagnostics market is broadly
segmented into polymerase chain reaction (PCR), in situ hybridization (ISH),
immunohistochemistry (IHC), next-generation sequencing (NGS), and other
technologies. In 2016, the polymerase chain reaction (PCR) segment
accounted for the largest share of this market and the next-generation
sequencing (NGS) segment is expected to register the highest CAGR during
the forecast period. The large share of the PCR segment is attributed to its
ease of use and to the fact that it does not require many samples for
biomarker identification.
https://www.marketsandmarkets.com/Market-Reports/companion-diagnostics-market-155571681.html